Clinical Practice: The role of biosimilar granulocyte colony stimulating factor (GCSF) Zarzio for progenitor cell mobilization and the treatment of therapy-induced neutropenia in adult hematopoietic stem cell transplantation
<p class="p1">Originator GCSF (Neupogen) has been used to mobilize progenitor stem cells and treat therapy-induced neutropenia in Canadian stem cell transplant settings for years. Although its benefit is not in question, viable alternatives are available. Biosimilar GCSF (Zarzio) is...
Main Author: | Cherie Severson |
---|---|
Format: | Article |
Language: | English |
Published: |
Pappin Communications
2015-10-01
|
Series: | Canadian Oncology Nursing Journal |
Online Access: | https://canadianoncologynursingjournal.com/index.php/conj/article/view/611 |
Similar Items
-
Use of Biosimilar Granulocyte Colony-Stimulating Factor for Mobilization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
by: Dwight D. Eplin, et al.
Published: (2019-10-01) -
ROLE OF GRANULOCYTE COLONY-STIMULATING FACTOR (GCSF)/FILGRASTIM AS AN ADJUNCT IN CHRONIC HEPATITIS C MANAGEMENT
by: Fazal A. Danish, et al.
Published: (2009-06-01) -
ROLE OF GRANULOCYTE COLONY-STIMULATING FACTOR (GCSF)/FILGRASTIM AS AN ADJUNCT IN CHRONIC HEPATITIS C MANAGEMENT
by: Fazal A. Danish, et al.
Published: (2009-06-01) -
Recombinant granulocyte colony stimulating factor biosimilars. Quality assessment
by: Zh. I. Avdeeva, et al.
Published: (2018-02-01) -
Immunoglobulin and granulocyte-colony stimulating factor affecting infection and hematopoietic reconstruction in allogeneic hematopoietic stem cell transplantation
by: Le Ma, et al.
Published: (2023-04-01)